For those who remember, the book is somehow a welcome addition to Ben Goldacre’s Bad Pharma published in 2012. Throughout the book the author investigates issues around the complex process of drug pricing, and how it is manipulated, and abused, for corporate gain. This is the premise of a new book, Sick Money, by journalist Billy Kenber, who has taken a deep dive into the harrowing business of the pharmaceutical industry. At the same time, patients in need of life-saving or life-improving medicines are increasingly driven to the internet in search of drugs that national health services cannot afford. The nature of drug research, how drugs are priced, and who has access to them is now dictated by corporate shareholders.
